Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-25 @ 4:26 AM
NCT ID:
NCT06975020
Eligibility Criteria:
Inclusion Criteria:
* Experience of smoking cannabis products, on average once a week. This may be in combination with tobacco.
* Age 18-65 years Possession of driving license in at least one of the categories A, B, A1; B1, F, G or M
* Sufficient knowledge of German
* No cannabis inhalation or nicotine consumption on study day
* No alcohol consumption within the last 24 h
Exclusion Criteria:
* Participation in a trial with investigational drugs within 30 days
* Current or previous major psychiatric disorder (e.g., major depression, schizophrenia spectrum disorder)
* Pregnancy or breastfeeding
* Intake of CYP2C9, CYP2C19, and CYP3A4-inducers in the last 4 weeks before the study visit, e.g. rifampicin (antibiotic), carbamazepine (anticonvulsant), phenobarbital (anticonvulsant), phenytoin (anticonvulsant) or inhibitors, such as amiodarone (class III antiarrhythmic medication), antifungal drugs such as fluconazole, miconazole, voriconazole and itraconazole, antibiotics such as clarithromycin and sulfamethoxazole, ritonavir (protease inhibitor) and grapefruit juice.
* The following conditions: vasopressin deficiency, pituitary tumor, active malignancy, severe hyponatremia requiring treatment, congestive heart failure, liver cirrhosis.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06975020
Study Brief:
Protocol Section:
NCT06975020